Wednesday
SESSION 24: PROGRESS IN LOWER EXTREMITY STENT BASED TREATMENTS FOR OCCLUSIVE LESIONS
Location: Grand Ballroom East, 3rd Floor
Moderators:Frank J. Veith, MD / Dierk Scheinert, MD  
SESSION 24 SCHEDULE
7:46 AM - 7:51 AM Optimal Treatment For Crural Artery Lesions In 2018 In The US And Elsewhere: Value Of Coronary Drug Eluting Stents (DESs): When And How To Use Them
  Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
7:52 AM - 7:57 AM Endovascular Stent Treatment Of Common Femoral Artery (CFA) Is Best For All Lesions: Based On The TECCO RCT (Stent vs. Open Endarterectomy): Classification Of Lesions And Subsequent Access Through Stents Is OK
  Presenter(s):Yann GouŽffic, MD, PhD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
7:58 AM - 8:03 AM Value Of Multiple Short Stents For Treating Fempop Long Lesions: Better Than A Full Metal Jacket: The LOCOMOTIVE Trial Of Vascuflex System (From B. Braun)
  Presenter(s):Thomas Zeller, MD / Peter C.J. Goverde, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
8:04 AM - 8:09 AM New Findings From The Zilver PTX DES 5-Year RCT And Other Studies Show The Advantages Of This Stent For Fempop Lesions
  Presenter(s):Michael D. Dake, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
8:10 AM - 8:15 AM Value And Limitations Of Zilver PTX DESs: How Do They Change The Pattern And Volume Of In-Stent Restenosis (ISR) Compared To Other Stents
  Presenter(s):Gary M. Ansel, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
8:16 AM - 8:21 AM ZILVER PASS RCT Comparing ZILVER PTX DES To PTFE Fempop Bypasses: For TASC C And D Lesions: Zilver PTX Is As Good Or Better At 2 Years
  Presenter(s):Marc Bosiers, MD / Koen R. Deloose, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
8:22 AM - 8:27 AM 2-Year Results Of The RAPID RCT Comparing Supera Stent Treatment For SFA Lesions With And Without A DCB
  Presenter(s):Jean-Paul de Vries, MD, PhD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
8:28 AM - 8:33 AM MAJESTIC DES Trial: 3-Year Results For Treatment In Superficial Femoral And Proximal Popliteal Lesions: How Does Eluvia Differ From Other DES
  Presenter(s):Stefan Mueller-Huelsbeck, MD / Thomas Zeller, MD / Dierk Scheinert, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
8:33 AM - 8:38 AM IMPERIAL Head To Head RCT: 1 Year Results Of The Eluvia DES vs. ZilverPTX For Fempop Lesions
  Presenter(s):William A. Gray, MD / Andrew Holden, MBChB  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
8:39 AM - 8:44 AM Status Of Bioresorbable DESs For Treating BTK Arteries: Though They Failed In The Coronary Arteries They Show Promise In The Leg: The ABSORB BTK Trial 4-Year Results Show Why
  Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
8:45 AM - 8:58 AM Panel Discussion
END OF SESSION 24
previous next